H3K27M mutation in adult cerebellar glioblastoma

Victor M Lu1, Oluwaseun O Akinduro2, David J Daniels1

  • 1Department of Neurologic Surgery, Mayo Clinic, Rochester, MN, United States.

Insights

The H3K27M mutation, typically found in pediatric brainstem gliomas, is now identified in adult cerebellar glioblastomas. This unexpected finding prompts a re-evaluation of brain tumor classification and treatment strategies.

Area of Science:

  • Neuro-oncology
  • Molecular biology
  • Genetics

Background:

  • The H3K27M mutation is a hallmark of pediatric diffuse midline glioma (DMG), predominantly affecting the brainstem.
  • Diffuse midline glioma (DMG) is a highly aggressive brain tumor in children.

Purpose of the Study:

  • To report the novel occurrence of the H3K27M mutation in adult glioblastoma (GBM) in the cerebellum.
  • To discuss the biological and clinical implications of this finding.

Main Methods:

  • Analysis of tumor genetic profiles.
  • Review of clinical data for adult GBM patients with H3K27M mutation.

Main Results:

  • Identification of the H3K27M mutation in adult malignant glioblastomas located in the cerebellum.
  • Unexpected prevalence of this mutation in a previously pediatric-associated tumor type.

Conclusions:

  • The presence of H3K27M mutation in adult cerebellar GBM challenges existing classifications.
  • This finding necessitates further investigation into the shared biology and potential therapeutic targets for pediatric and adult gliomas with H3K27M.